Your session is about to expire
← Back to Search
Device
Automated Eye Pressure Measurement for Glaucoma
N/A
Recruiting
Led By Joanne Wen, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≥ 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial is testing a new, automated way to measure eye pressure, which may be more accurate and portable than the current standard.
Who is the study for?
This trial is for adults over 18 who are coming in for a routine eye exam and can give consent. It's not suitable for those with a history of corneal scarring or an active eye infection.Check my eligibility
What is being tested?
The study is testing new automated methods to measure eye pressure against the standard Goldmann Applanation Tonometry (GAT). This includes two portable prototypes and aims to make the process more objective and repeatable.See study design
What are the potential side effects?
Since this trial involves non-invasive eye pressure measurements, side effects may be minimal but could include discomfort at the site of applanation or temporary visual disturbances.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intraocular pressure (IOP) as measured by fixed force GAT
Intraocular pressure (IOP) as measured by standard GAT
Intraocular pressure as measured by supine applanating protoype
+1 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Upright applanating prototypeExperimental Treatment1 Intervention
With this prototype, an applanating prism (custom manufactured with medical grade acrylic in an ISO-13485 certified facility) is attached to a fixed-force spring that creates a force equivalent to 1.8 or 2.0 on the GAT dial. Blue LED lights on the prototype are used to create the blue illumination similar to the blue light used in clinical practice on the slit lamp or Perkins tonometer. A C-MOS camera is aligned with the GAT prism to image the applanation mires. The eye is given topical fluorescein/anesthetic. Like fixed-force GAT, the GAT prism contacts the eye while the CMOS camera makes a video of the mire appearance. The diameters of the recorded mire images are measured and the IOP is calculated based on the mire diameter
Group II: Supine Applanating PrototypeExperimental Treatment1 Intervention
With this method, a 5 gram clear acrylic cylinder (custom manufactured with medical grade acrylic in an ISO-13485 certified facility) is aligned with the lens of the CMOS camera and the distal tip of the cylinder is illuminated with blue light using an LED similar to the blue light used in clinical practice on the slit lamp or Perkins tonometer. The eye is given topical fluorescein/anesthetic. While the CMOS camera is recording, the 5 gram weight will rest upon the eye and circular applanation mires are recorded. The diameters of the recorded mire images are measured and the IOP is calculated based on the mire diameter
Group III: Fixed-force GATExperimental Treatment1 Intervention
From the patient perspective, this method will feel identical to the standard GAT. The eye is given topical fluorescein/anesthetic. The GAT dial is set at 1.8 or 2.0, a C-MOS camera is connected to one of the oculars of the slit lamp machine and under blue light illumination, the GAT prism contacts the eye while the CMOS camera makes a video of the mire appearance through the ocular. The diameters of the recorded mire images are measured and the IOP is calculated based on the mire diameter
Group IV: Standard GATActive Control1 Intervention
This is the standard method for IOP measurement in clinical practice
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,355 Previous Clinical Trials
3,408,819 Total Patients Enrolled
13 Trials studying Glaucoma
2,606 Patients Enrolled for Glaucoma
Joanne Wen, MDPrincipal InvestigatorDuke Eye Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 or older and agree to participate.I have had scarring on my cornea.I am 18 years old or older.I have an active eye infection.
Research Study Groups:
This trial has the following groups:- Group 1: Supine Applanating Prototype
- Group 2: Standard GAT
- Group 3: Fixed-force GAT
- Group 4: Upright applanating prototype
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Can individuals participate in this research endeavor at the moment?
"Reports on clinicaltrials.gov indicate that this research has been actively recruiting since November 21, 2022 and the trial information was recently updated last month."
Answered by AI
How many participants have enrolled in this investigational research?
"Absolutely. According to clinicaltrials.gov, this particular investigation is actively recruiting participants which began on November 21st 2022 and was last updated on the 30th of that same month. This study requires 200 patients from a single trial site."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger